McKesson Corp (MCK)

McKesson Corp (MCK) has emerged as a strong player in the pharmaceutical logistics space, maintaining an extensive market share alongside two other major competitors, which collectively dominate 90% of the market. Despite a recent rotation away from healthcare into more exciting sectors, analysts are optimistic about McKesson's projected 12-13% earnings growth, though its stock trades slightly below key moving averages, raising some concerns. The company has demonstrated remarkable stability, bolstered by demographic trends favoring healthcare services, and has consistently enhanced its dividend over the past five years. Upcoming events, such as an expected earnings report, could serve as a catalyst for stock performance. Additionally, the planned spinoff of its medical/surgical unit is expected to unlock further value for investors.